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SUMMARY
One hundred and twenty-two asthmatic patients were identified with the help of
a microcomputer in a Belfast practice of 3140. Thirteen different diagnostic
labels were found to be used with up to five different labels used for a single
patient. Inadequate treatment was found in a small number ofpatients, which
was attributable to both doctor and patient. Regular monitoring using peak
expiratory flow occurred injust 14percent. Morefrequent use ofpeakexpiratory
flow monitoring both in the surgery and at home and better patient education
may go some way to reducing asthma morbidity and mortality.
INTRODUCTION
Deaths from asthma have failed to decline since the epidemic of the mid-1960s,
with 1500 patients dying per year in England and Wales.' The British Thoracic
Association in their study in 19822 found that avoidable factors were involved in
82 per cent ofdeaths. Delay in starting appropriate treatment wasthesingle most
important factor, due mainly to the failure of patients to recognise the severity of
the attack. Poor patient education and control, and the infrequent use ofsteroids
were also found to be significant. This study suggested to the authors the need to
perform an audit of asthma in an urban practice of 3140 patients, with objectives
which might point the way to improved patient management and education in the
future.
METHOD
Patients who had at some time been given a diagnostic label of asthma, or who
had taken one or more drugs commonly used for asthma, were identified through
the practice microcomputer.
Their A4 records were then assessed for appropriate history, investigations, drug
therapy, monitoring of progress, the degree of severity and hospital admissions.
Further information was obtained using a postal questionnaire completed
independently by each patient. Defaulters were followed up. Analysis was carried
out using a mainframe computer.
RESULTS
One hundred and twenty-two patients were identified. There were 63 males and
59 females (48.4%), ranging from 1 -81 years, with a mean age of35 years. The
prevalence of patients labelled asthmatic in the practice was 3.9 per cent.
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Thirteen different diagnostic labels were used to describe asthma in these
patients, of whom 67 (54.9%) had just one label, 41 (33.6%) had two, 10
(8.2%) had three, two (1.6%) had four, and two (1.6%) patients had five labels.
The commonest label was asthma in 89 (73.0% of patients), followed by wheezy
bronchitis in 30 (24.6%), bronchial asthma in 17 (14.0%), asthmatic bronchitis
in 12 (9.8%), wheezy tendency in nine (5.4%), and late onset asthma in
seven (5.7%). Ninety-one patients (74.6%) had mild asthma, 22 (18.0%)
had moderate asthma and nine (7.4%) had severe asthma. (See Table I for
definitions).
TABLE I
Definition ofseverity groups in asthma
Mild asthma Intermittent airways obstruction which responds completely
to inhaled or oral bronchodilators.
Moderate asthma Low grade recurrent or continuous airways obstruction,
requiring intermittent or continuous bronchodilator therapy
+/or inhaled steroids.
May require oral steroids occasionally.
Severe asthma Recurrent or continuous marked airways obstruction
requiring recurrent or continuous bronchodilator therapy
and inhaled steroids, complemented by short or long-term
oral steroids.
Seventy patients (57.4%) were considered to be atopic. Forty-eight (39.3%)
indicated on the questionnaire that their attacks were precipitated by specific
allergens ofwhich house dust wasthe most common, followed by pollens, animal
dander and house dust mite. Twenty-two patients (18.0%) had had skin testing
and 21 (17.3%) had had immunotherapy. Other precipitating factors were found
as indicated in Table II.
TABLE II
Otherprecipitating factors for asthma
DIURNAL VARIATION Symptoms maximum at night 80 (65.6%)
94 (77%) Symptoms maximum by day 14 (11.4%)
EMOTIONALLY INDUCED ATTACKS 43 (35.2 %)
EXERCISE INDUCED ATTACKS 31 (25.4%)
EXERCISE + EMOTIONALLY INDUCED ATTACKS 31 (25.4%)
A history ofsmoking was recorded in only 26.9% ofthe adults. Nineteen patients
(15.6%) smoked and 20 of the 33 children lived with smokers. Twenty-one
patients (17.2%) were not taking any drugs. Of these patients, four considered
themselves to have had no troublesome attacks in the last year, nine had had
one, three had had two, three had had three, and two had had six attacks. One of
these last two patients, a 14-year-old, complained of continuous wheeze and
cough and yet had attended the general practitioner only once. The otherpatient,
a four-year-old, had had frequent episodic symptoms and had attended the
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general practitioner four times in the last year. Ofthese 21 patients, 17 declared
they 'couldn't be better', two had 'mild' symptoms, one had 'moderate' symptoms
and one 'couldn't be worse'.
FIGURE
Relative drug usage
No. of patients
Salbutamol inhaler 50
Sodium chromoglycate 22
Beclomethasone inhaler 22
Theophylline S.R.T.* 22
No treatment 21
Salbutamol tabs. _ 13
Aminophyllin S.R.T. * 13
Terbutaline inhaler 8
Ipritropium bromide inhaler 8
Salbutamol syrup 6
Orciprenaline syrup 6
Prednisolone 6
Salbutamol rotacaps 5
Salbutamol nebules 3
Terbutaline S.R.T. * 3
Beclomethasone rotacaps 2
Terbutaline tabs. 2
Terbutaline syrup 2
Isoprenaline inhaler 2
Terbutaline nebules 1
Budesonide inhaler 1
*S.R.T. = sustained release tablet.
Salbutamol inhaler was the most common drug used by 50 patients (41%),
followed by sodium chromoglycate (18.0%) and beclomethasone inhaler 22
(18.0%) (Fig). Sixteen patients (13.1 %) considered themselves to have had 24
or more troublesome attacks in the last year and we assessed these to be in the
moderate and severe categories. (Table 1). Eleven of these patients were taking
bronchodilators, sodium chromoglycate and/or inhaled or oral steroids. The
remaining five patients were on either oral, inhaled or nebulised salbutamol, used
as required. Two of these five had continuous symptoms with 30 and 40 attacks
in the last year. Both had only attended the general practitioner once in that year.
Twenty patients (16.4%) had had at least one course of oral steroids or an
increase in steroids in the last year, the average length of a course being one
week. Seven of these patients were on continuous oral steroids. Of the 13 who
had had at least one course of oral steroids, nine were taking bronchodilators,
sodium chromoglycate and/or inhaled steroids, the remaining four were taking
only bronchodilators. One would question if this is adequate prophylaxis. The
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latter group included a 26-year-old who had frequent episodic symptoms and
required salbutamol ten times per day. She had attended the general practitioner
twice in the last year and had had 12 significant attacks in this time.
Twelve patients (9.8%) had been admitted to hospital in the last year, three of
whom had two admissions. Eight of these patients were on bronchodilators,
sodium chromoglycate and/or inhaled steroids. Of the remaining four, three
were children under seven years who were managed on oral or nebulised
bronchodilators and one was a 49-year-old male who had had two admissions in
the last year and was treated with short courses of steroids. He complained of
continuous cough and frequent episodic wheeze and dyspnoea, yet had attended
his general practitioner only once and was on salbutamol inhaler as required!
Twenty-two patients (18.0%) had at some time been followed up in the hospital
outpatient department for asthma. Twelve (9.8%) had obtained direct hospital
admission without contacting their general practitioner.
Peak flow rate was monitored at each attack in 17 patients (13.9%), irregularly in
40 (37.8%) and never in 43 (35.2%). It was not practical in 22 (18.0%). Of the
43 patients who had never had a peak flow rate measured, only three had a single
vitalograph reading and this was to demonstrate reversibility. Five out of the 16
patients who had had 24 or more significant acute attacks in one year had regular
monitoring, eight had irregular monitoring, two had none, and monitoring was
not practical in one case. Of the 20 patients who took oral steroids intermittently
or continuously, only five had regular monitoring, eight had irregular monitoring,
five had none, and with two it was not practical. Of the five patients who had
never had peak flow monitoring, one was on continuous oral steroids. Twenty-six
patients (21.3%) had vitalograph measurements carried out, which were mainly
used for diagnostic purposes to demonstrate reversibility.
DISCUSSION
This audit of asthma patients is an example of the use of a microcomputer in
practice to identify patients. One hundred and twenty-two asthmatics (3.9%)
were identified in a practice of 3140 patients. Thirteen different diagnostic labels
were used with up to five different labels used for a single patient. This indicates
difficulty in labelling the asthmatic and some labels may have been chosen to
avoid alarming the patient by the term 'asthma'. However, this can only lead to
confusion and possible undertreatment, particularly in a group practice of several
general practitioners. With good education and treatment, patients can only
benefit from knowing their diagnosis.
Inadequate use of prophylactic therapy (inhaled steroids, regular use of broncho-
dilators and sodium chromoglycate) has been confirmed, and the study shows
that this is not always the doctor's fault but can sometimes be attributed to lack of
patient compliance.
Shee et al3 and the British Thoracic Association in its study of 90 asthmatic
deaths,2 also found asthmatics inadequately treated and this again not only due
to poor doctor management: some patients ignored their asthma. The British
Thoracic Association found that only 47 per cent of patients co-operated fully in
their treatment and they found patients with severe symptoms who repeatedly
failed to renew prescriptions or to visit the doctor as requested. Does this failure
of the patient reflect a lack of knowledge about asthma? Or is it due to a wish to
ignore or forget their illness; or a fear ofpossible side- effects from their drugs, as
found by Harding and Modell?4
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The British Thoracic Association also found that deaths were more likely in those
with chronic persistent symptoms, or those who had had previous sudden or
severe attacks and unstable patterns with variable peak flow rates. Delay in
starting treatment was the single most important factor, due mostly to the patient
not recognising the severity of the attack. In the present study inadequate
monitoring using the peak flow meter and vitalograph was found. While the
condition ofthe patient can be assessed clinically to some degree from the history
and physical examination, an objective test is highly desirable.5 The peak flow
meter gives the doctor a simple tool with which he can assess the patient's
condition and the effectiveness of therapy.6
In well-motivated patients, peak flow rates could be used to monitor the patient's
day-to-day condition at home, so that impending attacks can be treated before
full development has occurred, as with diabetic patients who monitor their blood
sugars. This, with clear guidelines, could overcome some of the problems that
patients have in deciding when to seek help.
In conclusion, many asthmatics are receiving inadequate treatment due to both
patient and doctor failure, with poor monitoring of their condition. Better use of
inhalers, with regular peak flow rate monitoring by the general practitioner and
possibly home monitoring by the patient, patient diaries and better patient
education, maygosome wayin reducing asthma deathsand improving morbidity.
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